In this study, in vitro functional experiments demonstrated that knockdown of DDX49 significantly suppressed the proliferative activity and colony-forming capacity of CRC cells, suggesting that DDX49 may exert an oncogenic role in CRC. Here, DDX49 is linked to colorectal carcinoma.